Grace G. Shumaker

Hematology | Oncology

2500 N State St
Jackson, MS 39216

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer.

Phase II study of lapatinib in combination with vinorelbine, as first or second-line therapy in women with HER2 overexpressing metastatic breast cancer.

Journal: SpringerPlus

Published: January 01, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026